• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[注意缺陷多动障碍中的时间知觉受损]

[Impaired time perception in attention deficit hyperactivity disorder].

作者信息

Chutko L S, Yakovenko E A, Surushkina S Yu, Anisimova T I, Didur M D, Cherednichenko D V, Scheglova L V, Sosnina I B, Snegova E V

机构信息

Institute of Human Brain Russian Academy of Sciences, St. Petersburg, Russia.

Saint Petersburg State Pediatric Medical University, St. Petersburg, Russia.

出版信息

Zh Nevrol Psikhiatr Im S S Korsakova. 2025;125(6):55-61. doi: 10.17116/jnevro202512506155.

DOI:10.17116/jnevro202512506155
PMID:40577181
Abstract

OBJECTIVE

To examine time perception in children with attention deficit hyperactivity disorder (ADHD) and evaluate the effectiveness of Pantogam in relation to the main symptoms of the disease and the disorder of time perception.

MATERIAL AND METHODS

86 children with ADHD aged 10-13 years were observed. The study group included 56 children with a combined type of ADHD (ADHD-C) and 30 children with a predominance of inattention without hyperactivity (ADD). The control group consisted of 30 children aged 10 to 13 years without psychoneurological disorders. The following research methods were used in the work: the SNAP-IY questionnaire for a quantitative assessment of ADHD manifestations, the «Working Memory» method for assessing working memory, tasks for assessing and measuring time intervals, and a study using the «subjective minute» method to assess time perception disorders. Pantogam was used in a dose of 750 mg per day for 8 weeks to treat children with ADHD.

RESULTS

According to the SNAP-IY scale, the level of inattention in the study groups was significantly higher than the level of inattention in the control group, and the level of hyperactivity and impulsivity was significantly higher in children with ADHD-C compared to the ADHD group and the control group. When assessing working memory, a reliable decrease in the level of this indicator was found in children with both types of ADHD compared to the control group. Difficulties with time management, as assessed by parents, were noted in 88.4% of children in the study group and 36.7% of children in the control group. These disorders were especially pronounced in tasks requiring sustained attention (96.4% of children with ADHD-C and 73.3% of children with ADD). According to the results of tests for time perception, disturbances in time perception were revealed in both groups of children with ADHD. In ADHD-C, tachychrony was more pronounced, and for patients with ADD, it was typical to overestimate the elapsed time. When re-evaluating the condition of 56 children with ADHD-C after the end of the course of treatment with Pantogam, an improvement in the form of a reliable decrease in inattention and impulsivity, an improvement in working memory was recorded in 55.4% of cases. During a repeated study after the course of treatment, an improvement in time perception was also recorded.

CONCLUSION

Children with ADHD, in addition to the main symptoms (inattention, hyperactivity, impulsivity), significantly more often have pronounced problems with time management, and the normalizing effect of drugs for the treatment of ADHD is manifested not only in relation to the main symptoms of the disease, but also in relation to the normalization of time perception.

摘要

目的

研究注意缺陷多动障碍(ADHD)患儿的时间感知,并评估泛癸利酮(Pantogam)对该疾病主要症状及时间感知障碍的疗效。

材料与方法

观察86名年龄在10至13岁的ADHD患儿。研究组包括56名复合型ADHD(ADHD-C)患儿和30名以注意力不集中为主且无多动症状的ADHD(ADD)患儿。对照组由30名年龄在10至13岁、无精神神经疾病的儿童组成。本研究采用以下方法:使用SNAP-IY问卷对ADHD表现进行定量评估,采用“工作记忆”方法评估工作记忆,通过任务评估和测量时间间隔,并采用“主观分钟”法研究评估时间感知障碍。使用泛癸利酮以每日750mg的剂量对ADHD患儿进行为期8周的治疗。

结果

根据SNAP-IY量表,研究组的注意力不集中水平显著高于对照组,且ADHD-C患儿的多动和冲动水平显著高于ADD组和对照组。在评估工作记忆时,与对照组相比,两种类型ADHD患儿的该指标水平均出现可靠下降。据家长评估,研究组88.4%的患儿存在时间管理困难,而对照组这一比例为36.7%。这些障碍在需要持续注意力的任务中尤为明显(ADHD-C患儿中96.4%,ADD患儿中73.3%)。根据时间感知测试结果,两组ADHD患儿均存在时间感知障碍。在ADHD-C患儿中,时间加速更为明显,而ADD患儿则通常高估已过去的时间。在用泛癸利酮治疗结束后对56名ADHD-C患儿的病情进行重新评估时,55.4%的病例出现了注意力不集中和冲动可靠下降形式的改善,工作记忆也有所改善。在治疗过程后的重复研究中,时间感知也有改善。

结论

ADHD患儿除了存在主要症状(注意力不集中、多动、冲动)外,时间管理问题明显更为常见,治疗ADHD的药物的规范化作用不仅体现在该疾病的主要症状方面,还体现在时间感知的正常化方面。

相似文献

1
[Impaired time perception in attention deficit hyperactivity disorder].[注意缺陷多动障碍中的时间知觉受损]
Zh Nevrol Psikhiatr Im S S Korsakova. 2025;125(6):55-61. doi: 10.17116/jnevro202512506155.
2
Methylphenidate for children and adolescents with autism spectrum disorder.用于治疗自闭症谱系障碍儿童和青少年的哌醋甲酯
Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011144. doi: 10.1002/14651858.CD011144.pub2.
3
Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.多不饱和脂肪酸(PUFA)治疗儿童和青少年注意缺陷多动障碍(ADHD)。
Cochrane Database Syst Rev. 2023 Apr 14;4(4):CD007986. doi: 10.1002/14651858.CD007986.pub3.
4
Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.针对5至18岁儿童注意力缺陷多动障碍(ADHD)的家长培训干预措施。
Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD003018. doi: 10.1002/14651858.CD003018.pub3.
5
Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的多不饱和脂肪酸(PUFA)
Cochrane Database Syst Rev. 2012 Jul 11;2012(7):CD007986. doi: 10.1002/14651858.CD007986.pub2.
6
Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.安非他酮用于治疗成人注意力缺陷多动障碍(ADHD)。
Cochrane Database Syst Rev. 2017 Oct 2;10(10):CD009504. doi: 10.1002/14651858.CD009504.pub2.
7
Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.患有共病抽动障碍的儿童注意力缺陷多动障碍(ADHD)的药物治疗。
Cochrane Database Syst Rev. 2018 Jun 26;6(6):CD007990. doi: 10.1002/14651858.CD007990.pub3.
8
Cognitive-behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults.成人注意力缺陷多动障碍(ADHD)的认知行为干预措施
Cochrane Database Syst Rev. 2018 Mar 23;3(3):CD010840. doi: 10.1002/14651858.CD010840.pub2.
9
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的哌甲酯——非随机研究中不良事件的评估
Cochrane Database Syst Rev. 2018 May 9;5(5):CD012069. doi: 10.1002/14651858.CD012069.pub2.
10
Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy.兴奋剂和非兴奋剂药物治疗注意缺陷多动障碍和癫痫患者。
Cochrane Database Syst Rev. 2022 Jul 13;7(7):CD013136. doi: 10.1002/14651858.CD013136.pub2.